January 25, 2022
Tag: CAR-T
January 25, 2022
News & Observer: Former patient gives UNC $25 million to find better breast cancer treatment options
October 6, 2021
Gel enhances CAR-T immunotherapy benefits in brains surgically treated for glioblastoma
Researchers from UNC Lineberger and colleagues report pairing a newly developed gel with immunotherapy that was delivered to post-surgical lab models with glioblastoma improved the immunotherapy’s effectiveness.
September 23, 2021
Endpoint News: UNC researchers report a new way to charge CAR-T against solid tumors
September 23, 2021
Therapy using dual immune system cells effectively controls neuroblastoma
Hongwei Du, PhD, Gianpietro Dotti, MD, and colleagues developed a new therapeutic approach that has shown successful results in lab models.
June 28, 2021
BioWorld: Other news to note
April 23, 2021
Scientists make donation when cancer hits close to home
Barbara Savoldo, MD, PhD, and Gianpietro Dotti, MD, have established a fund to develop a CAR-T therapy for glioblastoma in honor of Savoldo's sister, Sonia.
March 4, 2021
Engineered safety switch curbs severe side effects of CAR-T immunotherapy
As part of a study led by Matthew Foster, MD, the advance was seen in a patient enrolled in a clinical trial using CAR-T to treat refractory acute B-cell leukemia.
January 25, 2021
European Medicines Agency awards priority designation for Hodgkin lymphoma CAR-T therapy
The European Medicines Agency granted priority medicines designation to Tessa Therapeutics’ CD30 targeted CAR-T therapy for patients with relapsed or refractory Hodgkin lymphoma.
January 6, 2021